Mindfulness for smoking cessation

Jackson, Sarah E; Brown, Jamie; Norris, Emma; Livingstone‐Banks, Jonathan; Hayes, Emily; Lindson, Nicola

doi:10.1002/14651858.cd013696.pub2

Cited by 18 publications

(15 citation statements)

References 108 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, the cue-reactivity paradigm is widely used as probe [ 88 ] for measuring addictive behavior, but there is significant heterogeneity in its application [ 88 , 89 ]. In this study, we will employ a publicly available addiction image library and followed a standard two-choice oddball paradigm design.…”

Section: Discussionmentioning

confidence: 99%

Effects of brief mindfulness training on smoking cue-reactivity in tobacco use disorder: Study protocol for a randomized controlled trial

Cheng,

Luo,

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Background The prevalence of Tobacco Use Disorder (TUD) represents a significant and pressing global public health concern, with far-reaching and deleterious consequences for individuals, communities, and healthcare systems. The craving caused by smoking cue is an important trigger for relapse, fundamentally hindering the cessation of cigarette smoking. Mindfulness interventions focusing on cue-reactivity was effective for the treatment of related dependence. Brief mindfulness training (BMT) meets the short-term needs for intervention but the effects still need to be examined. The objective of the present study is to investigate the impact of BMT intervention on smoking cue-reactivity among Chinese college students with TUD, to uncover the dynamic models of brain function involved in this process. Method A randomized control trial (RCT) based on electroencephalography (EEG) was designed. We aim to recruit 90 participants and randomly assign to the BMT and control group (CON) with 1:1 ratio. A brief mindfulness training will be administered to experimental group. After the intervention, data collection will be conducted in the follow-up stage with 5 timepoints of assessments. EEG data will be recorded during the smoking cue-reactivity task and ‘STOP’ brief mindfulness task. The primary outcomes include subjective reports of smoking craving, changes in EEG indicators, and mindfulness measures. The secondary outcomes will be daily smoking behaviours, affect and impulsivity, as well as indicators reflecting correlation between mindfulness and smoking cue-reactivity. To evaluate the impact of mindfulness training, a series of linear mixed-effects models will be employed. Specifically, within-group effects will be examined by analysing the longitudinal data. Additionally, the effect size for all statistical measurements will be reported, offering a comprehensive view of the observed effects. Discussion The current study aims to assess the impact of brief mindfulness-based intervention on smoking cue-reactivity in TUD. It also expected to enhance our understanding of the underlying processes involved in brain function and explore potential EEG biomarkers at multiple time points. Trial registration Trial registration number: ChiCTR2300069363, registered on 14 March 2023. Protocol Version 1.0., 10 April 2023.

show abstract

Section: Discussionmentioning

confidence: 99%

Effects of brief mindfulness training on smoking cue-reactivity in tobacco use disorder: Study protocol for a randomized controlled trial

Cheng,

Luo,

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…In 2019 and 2020, CTAG published six new reviews, updated 15 previously published reviews (Table 1) and published two new protocols for reviews that will be conducted during 2021. The new protocols concern the use of mindfulness for smoking cessation [8] and the impact of heated tobacco products on smoking cessation and reducing smoking prevalence [9].…”

Section: Methodsmentioning

confidence: 99%

Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews

et al. 2021

Self Cite

View full text Add to dashboard Cite

Aims To summarize evidence on tobacco addiction interventions published by the Cochrane Tobacco Addiction Group (CTAG) from 2019 to 2020. Methods Narrative summary of all new and updated Cochrane Reviews published by CTAG in 2019 and 2020, outlining key results and promising avenues for future research. Results CTAG published six new reviews and updated 15 reviews. There is high‐certainty evidence that combining fast‐acting nicotine replacement therapy (NRT) with transdermal patches helped more people to quit than single‐form NRT [risk ratio (RR) = 1.25, 95% confidence interval (CI) = 1.15–1.36, 14 studies, n = 11 356; I2 = 4%] and moderate‐certainty evidence that using NRT before quitting can increase quit rates more than using NRT from quit day onwards (RR = 1.25, 95% CI = 1.08–1.44, nine studies, n = 4395; I2 = 0%). Reducing smoking in order to quit completely results in similar quit rates to abrupt quitting (RR = 1.01, 95% CI= 0.87–1.17; I2 = 29%; 22 studies, n = 9219; moderate‐certainty). Electronic cigarettes may help more people quit than NRT (RR = 1.53, 95% CI = 1.21–1.93; I2 = 0%; four studies, n = 1924; moderate certainty), nicotine‐free electronic cigarettes (RR = 1.94, 95% CI = 1.21–3.13; I2 = 0%; five studies, n = 1447; moderate‐certainty) and behavioural/no support (RR = 2.61, 95% CI = 1.44–4.74; I2 = 0%; six studies, n = 2886; very low‐certainty). Varenicline may help prevent relapse in abstainers (RR = 1.23, 95% CI = 1.08–1.41; I2 = 82%; 11 studies, n = 1297; moderate‐certainty), but behavioural support did not prevent relapse (RR = 0.98, 95% CI = 0.87–1.11; I2 = 52%; 11 studies, n = 5523; moderate‐certainty). Financial incentives increased quit rates in the general population (RR = 1.49, 95% CI = 1.28–1.73; I2 = 33%; 30 studies, adjusted n = 20 097; high‐certainty) and during pregnancy (RR = 2.38, 95% CI = 1.54–3.69; I2 = 41%; nine studies, n = 2273; moderate‐certainty). This overview also provides detail on a wider range of interventions. Conclusions There is high certainty that using nicotine replacement therapy from quit day increases smoking abstinence and no further research is required. Evidence is less certain that nicotine replacement increases abstinence when used in higher doses tailored to particular groups of smokers or use prior to quit day, and further research would be helpful. There is moderate‐certainty evidence to support the use of e‐cigarettes as cessation aids, but research on their role in preventing relapse would be particularly helpful.

show abstract

“…18 Likewise, the existing evidence does not support mindfulness-based interventions. 19 III. Acupuncture and related therapies.…”

Section: Review Articlementioning

confidence: 99%

Silver Spike Point Therapy in smoking cessation

Al‐Zalabani

2023

SMJ

View full text Add to dashboard Cite

Mindfulness for smoking cessation

Cited by 18 publications

References 108 publications

Effects of brief mindfulness training on smoking cue-reactivity in tobacco use disorder: Study protocol for a randomized controlled trial

Effects of brief mindfulness training on smoking cue-reactivity in tobacco use disorder: Study protocol for a randomized controlled trial

Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews

Silver Spike Point Therapy in smoking cessation

Contact Info

Product

Resources

About